{"retracted":false,"update":{"timestamp":1426377600000,"doi":"10.1016/j.bmcl.2015.01.029","type":"err"},"doi":"10.1016/j.bmcl.2014.03.039","journal":"Bioorganic & Medicinal Chemistry Letters","publisher":"Elsevier BV","title":"Corrigendum to “Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction” [Bioorg. Med. Chem. Lett. 24 (9) (2014) 2110–2114]"}
